Prevalence and Factors Associated with Unsuccessful Pulmonary Tuberculosis Treatment in Thai Military Hospitals
Keywords:
Pulmonary tuberculosis, Prevalence, Associated factor, ThailandAbstract
Background: Thailand is one of high TB burden countries. Military hospitals have been providing TB care for both military officers and civilians. However, there has never been studies of TB treatment in these hospitals in large scale.
Objective: This study aimed to report prevalence and associated factors of unsuccessful pulmonary TB treatment outcomes among Thai military hospitals.
Materials and Methods: A cross-sectional study was conducted in nine military hospitals across four regions of Thailand. Data from 2012 to 2021 were collected which included demographic and follow-ups data. Outcomes were successful and unsuccessful treatment. Logistic regression was used for predicting associated factors of unsuccessful pulmonary TB treatment.
Results: Prevalence of unsuccessful TB treatment was 17.72%. Associated factors of unsuccessful treatment included being agriculturist, laborer and household business owner, fever and weight, not investigated sputum culture, abnormal liver function test (LFT) and blood urea nitrogen (BUN) at the start, positive sputum AFB and uninvestigated sputum AFB at second month follow-up, uninvestigated chest radiograph at fifth month and unmonitored weight throughout treatment. Protective factor was having cutaneous adverse reactions during follow-up.
Conclusion: Several factors associated with unsuccessful pulmonary TB treatment outcomes were system-related or individual factors. Establishing community-based treatment system can be a solution.
References
Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med. 2015; 5 (2): a017798. https://doi.org/10.1101/cshperspect.a017798 PMid:25359550 PMCid:PMC4315920
Global tuberculosis report 2021. Geneva: World Health Organization.
Thailand Operational Plan to End Tuberculosis 2017-2021. In: Bureau of Tuberculosis, Department of Disease Control, Ministry of Public Health.
Treatment of Tuberculosis: Guidelines. Geneva: World Health Organization.
National tuberculosis control programme guideline, Thailand, 2018. Bangkok: Bureau of Tuberculosis, Ministry of Public Health.
Charoensakulchai S, Limsakul M, Saengungsumalee I, Usawachoke S, Udomdech A, Pongsaboripat A, et al. Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand. Am J Trop Med Hyg. 2020; 102 (3): 553-61. https://doi.org/10.4269/ajtmh.19-0564 PMid:31933460 PMCid:PMC7056434
Khunthason S, Kaewkungwal J, Pan-Ngum W, Okascharoen C, Apidechkul T, Lawpoolsri S. The Factors associated with the unsuccessful tuberculosis treatment of hill tribe patients in Thailand. J Infect Dev Cties. 2020; 14 (1): 42-7. https://doi.org/10.3855/jidc.12029 PMid:32088683
Charoensakulchai S, Lertpheantum C, Aksornpusitpong C, Trakulsuk P, Sakboonyarat B, Rangsin R, et al. Sixyear trend and risk factors of unsuccessful pulmonary tuberculosis treatment outcomes in Thai Community Hospital. BMC Res Notes. 2021; 14 (1): 1-8. https://doi.org/10.1186/s13104-021-05504-z PMid:33750450 PMCid:PMC7941995
Chengsorn N, Bloss E, Anekvorapong R, Anuwatnonthakate A, Wattanaamornkiat W, Komsakorn S, et al. Tuberculosis services and treatment outcomes in private and public health care facilities in Thailand, 2004-2006. Int J Tuberc Lung Dis. 2009; 13 (7): 888-94.
Chandoevwit W. Labor market issues in Thailand. TDRI Quarterly Review. 2004; 19 (2): 10-5.
Zimmer Z, Amornsirisomboon P. Socioeconomic status and health among older adults in Thailand: an examination using multiple indicators. Soc Sci Med. 2001; 52 (8): 1297-311. https://doi.org/10.1016/S0277-9536(00)00232-X PMid:11281411
Nafae RM, Elshahat HM, Said AM, Ibrahim MA. Reviewing treatment outcomes of tuberculosis patients at Zagazig Chest Hospital (2008-2012). Egypt J Chest Dis Tuberc. 2017; 66 (4): 623-30. https://doi.org/10.1016/j.ejcdt.2017.10.006
Przybylski G, Dąbrowska A, Trzcińska H. Alcoholism and other sociodemographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment-data from ten years' observation at the Regional Centre of Pulmonology, Bydgoszcz, Poland. Med Sci Monit. 2014; 20: 444. https://doi.org/10.12659/MSM.890012 PMid:24643127 PMCid:PMC3965286
Singla R, Khan N, Al-Sharif N, Al-Sayegh M, Shaikh M, Osman M. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006; 10 (1): 74-9.
Tiewsoh JBA, Antony B, Boloor R. HIV-TB co-infection with clinical presentation, diagnosis, treatment, outcome and its relation to CD4 count, a cross-sectional study in a tertiary care hospital in coastal Karnataka. J Family Med Prim Care. 2020; 9 (2): 1160. https://doi.org/10.4103/jfmpc.jfmpc_950_19 PMid:32318485 PMCid:PMC7113982
Podewils L, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, et al. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect. 2011; 139 (1): 113-20. https://doi.org/10.1017/S0950268810000907 PMid:20429966
Kornfeld H, Sahukar SB, Procter-Gray E, Kumar NP, West K, Kane K, et al. Impact of diabetes and low body mass index on tuberculosis treatment outcomes. Clin Infect Dis. 2020;71(9): e392-e8. https://doi.org/10.1093/cid/ciaa054 PMid:31955202 PMCid:PMC7713690
Hoa N, Lauritsen J, Rieder H. Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis. 2013; 17 (1): 61-6. https://doi.org/10.5588/ijtld.12.0369 PMid:23146565
Warmelink I, Nick H, van der Werf TS, van Altena R. Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. Br J Nutr. 2011; 105 (3): 400-8. https://doi.org/10.1017/S0007114510003636 PMid:20875187
Maria N, Radji M, Burhan E. The impact of antituberculosis druginduced hepatotoxicity to succesful tuberculosis treatment in Indonesia. Asian J Pharm Clin Res. 2017; 10 (11): 194-8. https://doi.org/10.22159/ajpcr.2017.v10i11.20386
Yagui M, Perales M, Asencios L, Vergara L, Suarez C, Yale G, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis. 2006; 10 (8): 838-43.
Nagaraja C, Shashibhushan B, Asif M, Manjunath P, Sagar C. Pattern of drugresistance and treatment outcome in multidrug-resistant pulmonary tuberculosis. Ind J Chest Dis Allied Sci. 2012; 54 (1): 23-6. https://doi.org/10.5005/ijcdas-54-1-23
Pang Y, Du J, Zhang ZY, Ou XC, Li Q, Xia H, et al. The feasibility of sputum transportation system in China: effect of sputum storage on the mycobacterial detection. Biomed Environ Sci. 2014; 27 (12): 982-6.
Scheelbeek PF, Wirix AJ, Hatta M, Usman R, Bakker MI. Risk factors for poor tuberculosis treatment outcomes in Makassar, Indonesia. Southeast Asian J Trop Med Public Health. 2014; 45 (4): 853.
Chien J-Y, Chen Y-T, Shu C-C, Lee J-J, Wang J-Y, Yu C-J, et al. Outcome Correlation of Smear-Positivity for Acid-Fast Bacilli at the Fifth Month of Treatment in Non-Multidrug-Resistant TB. Chest. 2013; 143 (6): 1725-32. https://doi.org/10.1378/chest.12-2051 PMid:23288018
Muñoz-Sellart M, Cuevas L, Tumato M, Merid Y, Yassin M. Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. Int J Tuberc Lung Dis. 2010; 14 (8): 973-9.
Bushnell G, Stennis N, Drobnik A, Proops D, Ahuja S, Bornschlegel K, et al. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2015; 143 (9): 1972-81. https://doi.org/10.1017/S0950268814002970 PMid:25387450 PMCid:PMC9507265
Chen L, Bao D, Gu L, Gu Y, Zhou L, Gao Z, et al. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect Dis. 2018; 18 (1): 1-10. https://doi.org/10.1186/s12879-018-3192-8 PMid:29970037 PMCid:PMC6029116
Baghaei P, Marjani M, Tabarsi P, Moniri A, Rashidfarrokhi F, Ahmadi F, et al. Impact of chronic renal failure on antituberculosis treatment outcomes. Int J Tuberc Lung Dis. 2014; 18 (3): 352-6. https://doi.org/10.5588/ijtld.13.0726 PMid:24670575
Igari H, Imasawa T, Noguchi N, Nagayoshi M, Mizuno S, Ishikawa S, et al. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis. J Infect Chemother. 2015; 21 (8): 559-63. https://doi.org/10.1016/j.jiac.2015.04.008 PMid:26048063
Wakamatsu K, Nagata N, Kumazoe H, Honjyo S, Hara M, Nagaoka A, et al. Prognostic factors in patients with miliary tuberculosis. J Clin Tuberc Other Mycobact Dis. 2018; 12: 66-72. https://doi.org/10.1016/j.jctube.2018.07.001 PMid:31720401 PMCid:PMC6830168
Lehloenya RJ, Dheda K. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future. Expert Rev Anti Infect Ther. 2012; 10 (4): 475-86. https://doi.org/10.1586/eri.12.13 PMid:22512756
Rezakovic S, Pastar Z, Kostovic K. Cutaneous adverse drug reactions caused by antituberculosis drugs. Inflamm Allergy Drug Targets. 2014; 13 (4): 241-8. https://doi.org/10.2174/1871528113666140717113358 PMid:25039910
Laghari M, Talpur BA, Sulaiman SAS, Khan AH, Bhatti Z. Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis. Int J Microbiol. 2020; 9 (3): 281. https://doi.org/10.4103/ijmy.ijmy_75_20 PMid:32862161
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Greater Mekong Sub-region Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
